CartiLife (NCT05051332) Confirmatory Clinical Trial

A CartiLife (NCT05051332) Confirmatory Clinical Trial is a Confirmatory Clinical Trial that evaluates the safety and efficacy of CartiLife for the treatment of articular cartilage leasions.

• AKA: Therapeutic Confirmatory Clinical Trial to Evaluate the Safety and Efficacy of Treatment of Articular Cartilage Lesions With CartiLife.
• Context:
  • Clinical Trial Website: https://clinicaltrials.gov/ct2/show/NCT05051332
• Example(s):
  • …
• Counter-Example(s):
  • LDP-CDP1 (NCT04739111) Exploratory Clinical Trial.
• See: National Clinical Trial (NCT) Number, Clinical Trial, Decentralized Clinical Trial, Adaptive Clinical Trial, Pragmatic Clinical Trial, Exploratory Clinical Trial.

---

---

References

2021

• (ClinicalTrials.gov, 2021) ⇒ https://clinicaltrials.gov/ct2/show/NCT05051332 Last Update Posted: September 29, 2021.
  • QUOTE: This open-label, phase 3 study is being conducted to evaluate the safety and efficacy of pellet-type extracellular matrix-associated autologous chondrocytes (CartiLife®) compared with microfracture surgery in adults with articular cartilage defects due to trauma or degeneration of the knee. It is hypothesized that CartiLife treatment will demonstrate structural regeneration and improvement in function and pain at Week 48 compared to baseline.

---